Update on Wilson Disease

International Review of Neurobiology

Volumn 110, Issue , 2013, Pages 313-348

  Aggarwal, Annu ^a   Bhatt, Mohit ^a  

^a Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute   (India)

Author keywords

ATP7B gene; Copper; Decoppering; Global Assessment Scale for WD (GAS for WD); Hepatocellular degeneration; Kayser Fleischer rings; Penicillamine; Trientine; Wilson disease; Zinc

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CERULOPLASMIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; COPPER; DIMERCAPROL; GLUCONATE ZINC; MENKES PROTEIN; NEUROLEPTIC AGENT; PENICILLAMINE; TRIENTINE; WILSON DISEASE PROTEIN; ZINC; ZINC ACETATE; ZINC SULFATE;

ADVERSE OUTCOME; ALLERGIC REACTION; AMINO ACID SUBSTITUTION; ARTHROPATHY; ARTICLE; ASYMPTOMATIC DISEASE; ATP7B GENE; BEHAVIOR DISORDER; BLEEDING; BONE DISEASE; CERULOPLASMIN GENE; CLINICAL FEATURE; COGNITIVE DEFECT; COPPER DEFICIENCY; COPPER METABOLISM; DECOMPENSATED LIVER CIRRHOSIS; DNA MICROARRAY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELASTOSIS; EXTRAPYRAMIDAL SYNDROME; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FULMINANT HEPATIC FAILURE; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE PHENOTYPE CORRELATION; GLOBAL ASSESSMENT SCALE; GOODPASTURE SYNDROME; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HOMEOSTASIS; HUMAN; INCIDENTAL FINDING; IRON OVERLOAD; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; OPTIC NEURITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; SIDEROBLASTIC ANEMIA; SKIN BRUISING; STOMACH IRRITATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; WILSON DISEASE;

ATP7B GENE; COPPER; DECOPPERING; GLOBAL ASSESSMENT SCALE FOR WD (GAS FOR WD); HEPATOCELLULAR DEGENERATION; KAYSER-FLEISCHER RINGS; PENICILLAMINE; TRIENTINE; WILSON DISEASE; ZINC;

COPPER; HEPATOLENTICULAR DEGENERATION; HOMEOSTASIS; HUMANS;

EID: 84887254622     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-410502-7.00014-4     Document Type: Chapter

References (98)

1. Aggarwal A., Bhatt M. Emergent psychosis in Wilson's disease. Movement Disorders 2008, 23:S181.
2. Aggarwal A., Bhatt M. Recovery from severe neurological Wilson's disease with copper chelation. Movement Disorders 2012, 27:S71.
3. Aggarwal A., Jankharia G., Bhatt M. Clinical spectrum and pathological correlates of osseomuscular disability in Wilson's disease. Movement Disorders 2008, 23:S173-S174.
4. Aggarwal A., Nagral A., Jankharia G., Aggarwal N., Bhatt M. A novel global assessment scale for Wilson's disease (GAS for WD). Movement Disorders 2009, 24:509-518.
5. Aggarwal A., Chandhok G., Todorov T., Parekh S., Tilve S., Zibert A., et al. Wilson disease mutation pattern with genotype-phenotype correlations from western India: Confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations. Annals of Human Genetics 2013, 77:8. 10.1111/ahg.12024.
6. Bearn A.G. Genetic and biochemical aspects of Wilson's disease. The American Journal of Medicine 1953, 15:442-449.
7. Boudin G., Pépin B. Dégénérescence hépatolenticulaire: maladie de Wilson, pseudo-sclérose de Westphal-Strumpell 1959, Paris.
8. Bramwell B. Familial cirrhosis of the liver: Four cases of acute fatal cirrhosis in the same family, the patients being respectively nine, ten, fourteen and fourteen years of age: Suggested relationship to Wilson's progressive degeneration of the lenticular nucleus. Edinburgh Medical Journal 1916, 17:90-99.
9. Brewer G.J., Dick R.D., Johnson V.D., Brunberg J.A., Kluin K.J., Fink J.K. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. The Journal of Laboratory and Clinical Medicine 1998, 132:264-278.
10. Brewer G.J., Dick R.D., Johnson V.D., Fink J.K., Kluin K.J., Daniels S. Treatment of Wilson's disease with zinc XVI: Treatment during the pediatric years. The Journal of Laboratory and Clinical Medicine 2001, 137:191-198.
11. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genetics 1993, 5(4):327-337. 10.1038/ng1293-327.
12. Bull P.C., Cox D.W. Wilson disease and Menkes disease: New handles on heavy-metal transport. Trends in Genetics 1994, 10:246-252.
13. Caca K., Ferenci P., Kuhn H.J., Polli C., Willgerodt H., Kunath B., et al. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. Journal of Hepatology 2001, 35(5):575-581.
14. Castilla-Higuero L., Romero-Gomez M., Suarez E., Castro M. Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease. Hepatology 2000, 32:877.
15. Catana A.M., Medici V. Liver transplantation for Wilson disease. World Journal of Hepatology 2012, 4:5-10.
16. Chuang L.M., Wu H.P., Jang M.H., Wang T.R., Sue W.C., Lin B.J., et al. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease. Journal of Medical Genetics 1996, 33(6):521-523.
17. Coffey A.J., Durkie M., Hague S., McLay K., Emmerson J., Lo C., et al. A genetic study of Wilson's disease in the United Kingdom. Brain 2013, 136(Pt 5):1476-1487. 10.1093/brain/awt035.
18. Coronado V.A., Damaraju D., Kohijoki R., Cox D.W. New haplotypes in the Bedlington terrier indicate complexity in copper toxicosis. Mammalian Genome 2003, 14(7):483-491. 10.1007/s00335-002-2255-3.
19. Culotta V.C., Yang M., O'Halloran T.V. Activation of superoxide dismutases: Putting the metal to the pedal. Biochimica et Biophysica Acta 2006, 1763:747-758.
20. Cumings J.N. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 1948, 71(Pt. 4):410-415.
21. Cumings J.N. The effects of BAL in hepatolenticular degeneration. Brain 1951, 74:10-22.
22. Curtis D., Durkie M., Balac P., Sheard D., Goodeve A., Peake I., et al. A study of Wilson disease mutations in Britain. Human Mutation 1999, 14(4):304-311. 10.1002/(SICI)1098-1004(199910)14:4<304::AID-HUMU5>3.0.CO;2-W.
23. Członkowska A., Tarnacka B., Litwin T., Gajda J., Rodo M. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period. Journal of Neurology 2005, 252:698-703.
24. Czlonkowska A., Rodo M., Gromadzka G. Late onset Wilson's disease: therapeutic implications. Movement Disorders 2008, 23(6):896-898. 10.1002/mds.21985.
25. Czlonkowska A., Gromadzka G., Chabik G. Monozygotic female twins discordant for phenotype of Wilson's disease. Movement Disorders 2009, 24(7):1066-1069. 10.1002/mds.22474.
26. Dastur D.K., Manghani D.K., Wadia N.H. Wilson's disease in India. I. Geographic, genetic, and clinical aspects in 16 families. Neurology 1968, 18:21-31.
27. Deguti M.M., Genschel J., Cancado E.L., Barbosa E.R., Bochow B., Mucenic M., et al. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Human Mutation 2004, 23(4):398. 10.1002/humu.9227.
28. Denny Brown D., Porter H. The effects of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). The New England Journal of Medicine 1951, 245:917-925.
29. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: Impact on genetic testing. Human Genetics 2006, 120:151-159.
30. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., et al. Diagnosis and phenotypic classification of Wilson disease. Liver International 2003, 23:139-142.
31. Firneisz G., Lakatos P.L., Szalay F., Polli C., Glant T.T., Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. American Journal of Medical Genetics 2002, 108(1):23-28.
32. Gaffney D., Fell G.S., O'Reilly D.S. Wilson's disease: Acute and presymptomatic laboratory diagnosis and monitoring. Journal of Clinical Pathology 2000, 53:807-812.
33. Gill H.H., Shankaran K., Desai H.G. Wilson's disease: Varied hepatic presentations. Indian Journal of Gastroenterology 1994, 13:95-98.
34. Glazebrook A.J. Wilson's disease. Edinburgh Medical Journal 1945, 52:83-87.
35. Golding D.N., Walshe J.M. Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients. Annals of the Rheumatic Diseases 1977, 36:99-111.
36. Gromadzka G., Schmidt H.H., Genschel J., Bochow B., Rodo M., Tarnacka B., et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clinical Genetics 2005, 68(6):524-532. 10.1111/j.1399-0004.2005.00528.x.
37. Gu Y.H., Kodama H., Du S.L., Gu Q.J., Sun H.J., Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clinical Genetics 2003, 64(6):479-484.
38. Gupta A., Aikath D., Neogi R., Datta S., Basu K., Maity B., et al. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Human Mutation 2005, 118(1):49-57. 10.1007/s00439-005-0007-y.
39. Hall H.C. La degenerescence hepatolenticulare. Maladie de Wilson-pseudosclerose 1921, Mason, Paris.
40. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T.A., Gitlin J.D. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proceedings of the National Academy of Sciences 1995, 92:2539-2543.
41. Haurowitz F. Ubereine anamoliedes kupferstoffwechsels. Hoppe-Seyler's Zeitschrift 1930, 90:72-74.
42. Kaler S.G. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. American Journal of Clinical Nutrition 1998, 67:1029S-1034S.
43. Kenney S.M., Cox D.W. Sequence variation database for the Wilson disease copper transporter, ATP7B. Human Mutation 2007, 28:1171-1177.
44. Kodama H., Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatrics International 1999, 41:430-435.
45. Korman J.D., Volenberg I., Balko J., Webster J., Schiodt F.V., Squires R.H., et al. Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests. Hepatology 2008, 48:1167-1174.
46. Kumar S., Thapa B.R., Kaur G., Prasad R. Identification and molecular characterization of 18 novel mutations in the ATP7B gene from Indian Wilson disease patients: genotype. Clinical Genetics 2005, 67(5):443-445. 10.1111/j.1399-0004.2005.00440.x.
47. Lang C.J., Rabas-Kolominsky P., Engelhardt A., Kobras G., Konig H.J. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Archives of Neurology 1993, 50:1007-1008.
48. Lee V.D., Northup P.G., Berg C.L. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: A potential therapeutic option?. Clinical Gastroenterology and Hepatology 2006, 4:1069-1071.
49. Lee B.H., Kim J.H., Lee S.Y., Jin H.Y., Kim K.J., Lee J.J., et al. Distinct clinical courses according to presenting phenotypes and their correlations to ATP7B mutations in a large Wilson's disease cohort. Liver International 2011, 31(6):831-839. 10.1111/j.1478-3231.2011.02503.x.
50. Litwin T., Gromadzka G., Czlonkowska A. Neurological presentation of Wilson's disease in a patient after liver transplantation. Movement Disorders 2008, 23(5):743-746. 10.1002/mds.21913.
51. Lutsenko S., Barnes N.L., Bartee M.Y., Dmitriev O.Y. Function and regulation of human copper-transporting ATPases. Physiological Reviews 2007, 87:1011-1046.
52. Mak C.M., Lam C.W. Diagnosis of Wilson's disease: A comprehensive review. Critical Reviews in Clinical Laboratory Sciences 2008, 45:263-290.
53. Marcellini M., Di Ciommo V., Callea F., Devito R., Comparcola D., Sartorelli M.R., et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: A single-hospital, 10-year follow-up study. The Journal of Laboratory and Clinical Medicine 2005, 145:139-143.
54. Martins da Costa C., Baldwin D., Portmann B., Lolin Y., Mowat A.P., Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992, 15:609-615.
55. Mishra D., Kalra V., Seth R. Failure of prophylactic zinc in Wilson disease. Indian Pediatrics 2008, 45:151-153.
56. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987, 37:761-767.
57. Nicastro E., Ranucci G., Vajro P., Vegnente A., Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010, 52:1948-1956.
58. Okada T., Shiono Y., Hayashi H., Satoh H., Sawada T., Suzuki A., et al. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Human Mutation 2000, 15(5):454-462. 10.1002/(SICI)1098-1004(200005)15:5<454::AID-HUMU7>3.0.CO;2-J.
59. Pfeiffer R.F. Wilson's disease. Handbook of Clinical Neurology 2011, 100:681-709.
60. Prashanth L.K., Taly A.B., Sinha S., Arunodaya G.R., Swamy H.S. Wilson's disease: Diagnostic errors and clinical implications. Journal of Neurology, Neurosurgery, and Psychiatry 2004, 75:907-909.
61. Prohaska J.R., Gybina A.A. Intracellular copper transport in mammals. Journal of Nutrition 2004, 134:1003-1006.
62. Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: An update. Hepatology 2008, 47:2089-2111.
63. Rosencrantz R., Schilsky M. Wilson disease: Pathogenesis and clinical considerations in diagnosis and treatment. Seminars in Liver Disease 2011, 31:245-259.
64. Rumpel A. Uber das Wesen und die Bedeutung der Leberveranderungen und der pigmentierunen bie den damit verbunden Fallen von Pseudosclerose, zugleich ein Beitrag zur Lehre von der seudosclerose (Westphal-Strumpell). Deutsche Zeitschrift Nervenheilkunde 1913, 49:54-73.
65. Santhosh S., Shaji R.V., Eapen C.E., Jayanthi V., Malathi S., Chandy M., et al. ATP7B mutations in families in a predominantly Southern Indian cohort of Wilson's disease patients. Indian Journal of Gastroenterology 2006, 25(6):277-282.
66. Scheinberg I.H., Sternlieb I. Wilson's disease. Major problems in internal medicine 1984, Elsevier Publishing, Philadelphia.
67. Scheinberg I.H., Sternlieb I. Treatment of the neurologic manifestations of Wilson's disease. Archives of Neurology 1995, 52:339-340.
68. Schilsky M.L., Scheinberg I.H., Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991, 100:762-767.
69. Schmidt H.H. Role of genotyping in Wilson's disease. Journal of Hepatology 2009, 50:449-452.
70. Siemerling E., Oloff H. Pseudosclerose (Westphal-Strumpell) mit cornealring (Kayser-Fleischer) und doppelseitger scheinkatarakt, die nur bei seitlicherbeleuchtung sichtbar ist und die, der nach verletzung durch kupfersplitterentstehenden katarakt ahnlich ist. Klinische Wochenschrift 1922, 1:1087-1089.
71. Sinha S., Taly A.B. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: Promising, safe and cheap. Journal of Neurological Sciences 2008, 15:129-132.
72. Stapelbroek J.M., Bollen C.W., van Amstel J.K., van Erpecum K.J., van Hattum J., van den Berg L.H., et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. Journal of hepatology 2004, 41(5):758-763. 10.1016/j.jhep.2004.07.017.
73. Stamelou M., Lai S.C., Aggarwal A., Schneider S.A., Houlden H., Yeh T.H., et al. Dystonic opisthotonus: A "red flag" for neurodegeneration with brain iron accumulation syndromes?. Movement Disorders 2013, 28:1325-1329. In print.
74. Sternlieb I., Scheinberg I.H. Prevention of Wilson's disease in asymptomatic patients. The New England Journal of Medicine 1968, 15:52-59.
75. Sternlieb I., Scheinberg I.H. Chronic hepatitis as a first manifestation of Wilson's disease. Annals of Internal Medicine 1972, 76:59-64.
76. Subramanian I., Vanek Z.F., Bronstein J.M. Diagnosis and treatment of Wilson's disease. Current Neurology and Neuroscience Reports 2002, 2:317-323.
77. Taly A.B., Meenakshi-Sundaram S., Sinha S., Swamy H.S., Arunodaya G.R. Wilson disease: Description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007, 86:112-121.
78. Taly A.B., Prashanth L.K., Sinha S. Wilson's disease: An Indian perspective. Neurology India 2009, 57(5):528-540. 10.4103/0028-3886.57789.
79. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genetics 1993, 5(4):344-350. 10.1038/ng1293-344.
80. Thomas G.R., Forbes J.R., Roberts E.A., Walshe J.M., Cox D.W. The Wilson disease gene: spectrum of mutations and their consequences. Nature Genetics 1995, 9(2):210-217. 10.1038/ng0295-210.
81. Todorov T., Savov A., Jelev H., Panteleeva E., Konstantinova D., Krustev Z., et al. Spectrum of mutations in the Wilson disease gene (ATP7B) in the Bulgarian population. Clinical Genetics 2005, 68(5):474-476. 10.1111/j.1399-0004.2005.00516.x.
82. Tümer Z., Møller L.B. Menkes disease. European Journal of Human Genetics 2010, 18:511-518.
83. Vogt A. Kupfer und silber aufgespeichert in auge, leber, milz und nieren als symptom der pseudosklerose. Klinische Monatsblatter Augenheilkunde 1929, 83:417-419.
84. Walshe J.M. Wilson's disease. New oral therapy. Lancet 1956, 267:25-26.
85. Walshe J.M. Wilson's disease. The presenting symptoms. Archives of Disease in Childhood 1962, 37:253-256.
86. Walshe J.M. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Quarterly Journal of Medicine 1973, 42:441-452.
87. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982, 1:643-647.
88. Walshe J.M. Wilson's disease patients can be decoppered. Lancet 1989, 22(2):228.
89. Walshe J.M. History of Wilson's disease: 1912 to 2000. Movement Disorders 2006, 21(2):142-147. 10.1002/mds.20694.
90. Walshe J.M. Cause of death in Wilson disease. Movement Disorders 2007, 22:2216-2220.
91. Walshe J.M. The conquest of Wilson's disease. Brain 2009, 132:2289-2295.
92. Walshe J.M., Dixon A.K. Dangers of non-compliance in Wilson's disease. Lancet 1986, 1:845-847.
93. Walshe J.M., Yealland M. Wilson's disease: the problem of delayed diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry 1992, 55(8):692-696.
94. Walshe J.M., Munro N.A. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Archives of Neurology 1995, 52:10-11.
95. Weiner W.J., Lang A.E. Wilson's disease. Movement disorders-A comprehensive survey 1989, 257-291. Futura, New York. W.J. Weiner, A.E. Lang (Eds.).
96. Wilson S.A.K. Progressive lenticular degeneration: A familial nervous disease with cirrhosis of the liver. Brain 1912, 34:295-507.
97. Wu Z., Wang N., Murong S., Lin M. Identification and analysis of mutations of the Wilson disease gene in Chinese population. Chinese Medical Journal 2000, 113(1):40-43.
98. Yarze J.C., Martin P., Muñoz S.J., Friedman L.S. Wilson's disease: Current status. The American Journal of Medicine 1992, 92:643-654.